October 01, 2015
Article
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).
Years After My Diagnosis, I Still Can’t Shake the Cancer Hound That Chases Me
A ‘Lighthouse Through the Cancer Storm’
Cancer Creates Empathy, But Hope Must Prevail
Creating an Extraordinary Environment for Cancer Healing